FLT3-IN-32
FLT3-IN-32 is a potent and orally active FLT3 inhibitor. FLT3-IN-32 shows high selectivity for FLT3 and efficiently inhibits FLT3-activating mutations and induces apoptosis. FLT3-IN-32 shows good tolerability in non-tumor bearing mice. FLT3-IN-32 demonstrates outstanding anti-tumor efficacy in MV4-11 bearing NOD/SCID mice, prolonging the survival noticeably. FLT3-IN-32 can be used for the research of acute myeloid leukemia.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3047195-48-9
- Formel: C28H29N5O5
- Molecular Weight:515.56
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
FLT3-IN-32 (Compound 29c) (0.3-218.7 nM, 72 h) effectively inhibits the proliferation in four different Ba/F3 cell lines expressing mutant FLT3 isoforms[1].
FLT3-IN-32 shows promising (1 μM-1 M) selectivity and safety toward FLT3-ITD-positive cells[1].
FLT3-IN-32 (100-500 nM, 48 h) induces apoptosis in four different Ba/F3 cell lines expressing mutant FLT3 isoforms[1].
FLT3-IN-32 (1-50 nM, 4 h) decreases the levels of phosphorylation of FLT3 and its downstream signaling molecules (STAT5, MAPK)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Ba/F3 pMIY FLT3-ITD (NPOS), Ba/F3 pMIY FLT3 D835Y, Ba/F3 pMIY FLT3 NPOS D835Y, Ba/F3 pMIY FLT3 NPOS N 676K cells
-
Concentration:0.3-218.7 nM
-
Incubation Time:72 h
-
Result:Showed effectively inhibition with IC50 values of 0.29 nM, 0.77 nM, 11.69 nM and 2.07nM, respectively.
-
Cell Line:Ba/F3 pMIY FLT3-ITD (NPOS), Ba/F3 pMIY FLT3 D835Y, Ba/F3 pMIY FLT3 NPOS D835Y, Ba/F3 pMIY FLT3 NPOS N 676K cells
-
Concentration:5, 20, 100,and 500 nM
-
Incubation Time:48 h
-
Result:Showed highly potent in inducing apoptotsis in FLT3 D835Y cells (54.11 %) and FLT3 NPOS N676K cells (38.43 %) at 100 nM.
-
Cell Line:Ba/F3 pMIY FLT3-ITD (NPOS) cells
-
Concentration:1, 5, 10, 20, and 50 nM
-
Incubation Time:4 h
-
Result:Decreased the levels of phosphorylation of FLT3 and its downstream signaling molecules including STAT5, MAPK and to a lesser extent also AKT in a concentration-dependent manner.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:MV4-11 CDX (cell-line derived xenograft) model in non-tumor bearing NOD/SCID mice (female, 8-9 weeks)[1]
-
Dosage:50 mg/kg
-
Administration:Oral administration, daily for 5 days
-
Result:Showed less relative body weight loss compared to Quizartinib (HY-13001) and comparable with Midostaurin (HY-10230).
Showed similarly inhibitive activity as Quizartinib (HY-13001) and much more active than Midostaurin (HY-10230).
-
Animal Model:Non-tumor bearing NOD/SCID mice (female, 6-8 weeks)[1]
-
Dosage:20, 50, 75 mg/kg
-
Administration:Oral administration, Intraperitoneal injection (20, 50 mg/kg), 15 days
-
Result:Showed good tolerability.
Chemical Information
-
CAS. Nr. 3047195-48-9
-
Molecular Weight 515.56
-
Formel C28H29N5O5
-
SMILES
O=C(NC1=CC=C(OC(C(C(N2)=CC3=C2C=CC(O)=C3CN(C)C)=O)=C4)C4=C1)NC5=NOC(C(C)(C)C)=C5
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)